chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itchy rash on that started outside the area of the injection; Itchy rash on that started outside the area of the injection, rash on again when taking a shower; The left arm as quart size to half dollar size black to blue mark; The left arm as quart size to half dollar size black to blue mark; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (The left arm as quart size to half dollar size black to blue mark), VACCINATION SITE DISCOLOURATION (The left arm as quart size to half dollar size black to blue mark), VACCINATION SITE PRURITUS (Itchy rash on that started outside the area of the injection) and VACCINATION SITE RASH (Itchy rash on that started outside the area of the injection, rash on again when taking a shower) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heartburn. Concurrent medical conditions included Migraine, Arthritis, Hypertension (Blood pressure) and Sleep difficult. Concomitant products included CETIRIZINE for Allergy, NAPROXEN for Arthritis, OMEPRAZOLE for Heartburn, MEDROXYPROGESTERONE and ESTRADIOL for Hormone replacement therapy, HYDROCHLOROTHIAZIDE for Hypertension, ALPRAZOLAM for Insomnia, SUMATRIPTAN for Migraine, FLUTICASONE PROPIONATE, PROPANOL, VENLAFAXINE, CYCLOBENZAPRINE, CORTISONE and MARIJUANA for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE BRUISING (The left arm as quart size to half dollar size black to blue mark), VACCINATION SITE DISCOLOURATION (The left arm as quart size to half dollar size black to blue mark) and VACCINATION SITE RASH (Itchy rash on that started outside the area of the injection, rash on again when taking a shower). On 17-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy rash on that started outside the area of the injection). On 12-Apr-2021, VACCINATION SITE BRUISING (The left arm as quart size to half dollar size black to blue mark) and VACCINATION SITE DISCOLOURATION (The left arm as quart size to half dollar size black to blue mark) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itchy rash on that started outside the area of the injection) had resolved and VACCINATION SITE RASH (Itchy rash on that started outside the area of the injection, rash on again when taking a shower) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the vaccination site bruise was easily bruised It was reported that the patient is scheduled for cortisone knee injections for both legs on 22-APR-2021 Treatment using cortisone gel over the counter was reported
Patient was given immunizations after he and his mother completed the consent form.  Approximately 12 minutes later  we heard a crash sound some form the exam room and we entered the room to find the patient on the floor.  He was alert, disoriented momentarily but was able to tell me his name, where he was and who I was right away. We helped him to the chair and called his mom into the room. She was in her car due  to the Covid Pandemic. He was pale and complained of nausea. He did not vomit. His vital signs were assessed and found to have low blood pressure and heart rate.  He drank juice and we reassessed 10 mins later and he had normal blood pressure and heart rate and his color returned to normal. He was able to talk and laugh. We discharged him home. We followed up by phone at 24 hours and 48 hours after the event and his mother reported he is doing well. with no new concerns or symptoms.
DIZZINESS,PAIN ON INJECTION SITE, HEADACHE,FEVER,SWELLINGON INJECTION SITE.3 DAYS OF SINTOMES.
Joint pain in neck, took prescription pain killers, did not work. Will probably return to center, if pain still exists.
SKIN FELT HOT TO TOUCH; SWELLING OF THROAT; SWEATING; BODY ACHES (UPPER CHEST, BACK AND LEFT HIP AREA); FELT FREEZE COLD; HEADACHE IN OCCIPITAL LOBE; This spontaneous report received from a patient concerned a 20 year old female. The patient's weight was 168 pounds, and height was 60 inches. The patient's concurrent conditions included post traumatic stress disorder, social anxiety, avoidant personality, non-alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies and had no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 294A21A, expiry: UNKNOWN) dose was not reported, administered on 27-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On NOV-2020, Laboratory data included: COVID-19 rapid POC test (NR: not provided) Negative. On 28-MAY-2021, the subject experienced skin felt hot to touch. On 28-MAY-2021, the subject experienced swelling of throat. On 28-MAY-2021, the subject experienced sweating. On 28-MAY-2021, the subject experienced body aches (upper chest, back and left hip area). On 28-MAY-2021, the subject experienced felt freeze cold. On 28-MAY-2021, the subject experienced headache in occipital lobe. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from sweating, and had not recovered from felt freeze cold, skin felt hot to touch, swelling of throat, headache in occipital lobe, and body aches (upper chest, back and left hip area). This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case is assessed as non serious.
After shot given, warm feeling above injection shot area (warm-to-touch). Treated with ice pack and monitored. Had a doctor look at area. Next day: bump under injection site, warm-to-touch, itchy, headache, chills and slight temp around 7 pm. I was tired and slept. Wed: injection site red, warm, itchy, bump underneath, headache off/on and tired. Thurs: injection site red, warm, itchy, bump underneath and headache. Treatment: Tylenol as needed for headache. Monitored redness and bump by injection site.
dysautonomia; This spontaneous report has been received from the patient's mother via social media and website "Dependent" via vendor, referring to a 12-year-old female patient. Her pertinent medical history, drug reactions, allergies or concomitant medication were not reported.   On an unknown date, the patient was vaccinated with unidentified Merck hpv vaccine unclear if it was HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) or Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) injection (route, dose, anatomical location of vaccination, lot# and expiration date were not reported) for prophylaxis.  On an unknown date, the patient was diagnosed with dysautonomia. It was reported that typically, people with dysautonomia did not perform well in the morning as it took hours for their bodies to function and bagin their day. The patient was started on blood pressure medication, followed by a vasoconstrictor medicine, followed by a medicine used for people with Attention Deficit Disorder. These medicines all helped push more blood to the heart and brain, thus making her illness less violent. It was reported that despite treatment, the patient could not get back to functioning like a teenager. The reporter requested a second and third opinion and a doctor finally admitted that they had seen an increase in dysautonomia since the HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) or Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) vaccine (unclear which one) was introduced. By the reporting time, the patient had not recovered from the event.   The reporter considered dysautonomia to be related to unidentified Merck hpv vaccine (HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) or Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL)).  Upon internal review, dysautonomia was considered to be a disabling event as the patient could not get back to functioning like a teenager.
Initial report was received 11 August 2010 with additional information received on 16 August 2010 from a health care professional which involved a cluster of eight patients who tested positive for pertussis. Patient identifiers were provided for seven patients; two who had previously received ADACEL (captured in case numbers 2010-04349 and 2010-04350); and three who had previously received an unspecified TdaP vaccine (captured in case numbers 2010-04352, 2010-04353 and 2010-04354), and two patients who had not received ADACEL, but had previously received a full DtaP vaccination series (captured in this case (2010-04376) and case number 2010-04351). At the time of the report, no information was available for the eight unidentified patient. A 9-year-old female patient had received five previous injections of DtaP (manufacturers, lot numbers, routes and sites of administration not reported) and an unspecified amount of time later on 21 June 2010, she was diagnosed with pertussis. Laboratory test results were positive for pertussis. Outcome was not reported and no further information was provided at the time of the report. Documents held by sender: None.
Lymph node pain; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of LYMPH NODE PAIN (Lymph node pain) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced LYMPH NODE PAIN (Lymph node pain). At the time of the report, LYMPH NODE PAIN (Lymph node pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.  The physician told her that before receiving the second vaccine, she should take 1 tylenol, 1 pepcid, and 1 benadadryl day before the vaccination, the night of the vaccination, and the day after the vaccination.
injection site reaction Narrative: Fever 100 degrees lasted less than 24 hours, and sore arm lasted than 24 hours
Severe headache, dizziness, chest tightness, shortness of breathe, weakness- unable to stand more than a minute or 2- turned into double pneumonia- started 10/30/2021- lasted over 3 weeks- out of work for extended period of time
i had scleritis; This is a spontaneous report from a contactable consumer. A 48-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in left arm on 31Mar2021 12:00 (Batch/Lot Number: ER8737) as 1st dose, single for Covid-19 immunisation. Medical history included tear meniscus and menstural irregularity. Concomitant medications were not reported. On an unspecified date, the patient had scleritis. She was tested for any cause of sickness in blood test and everything was negative. The outcome of the event was unknown.   Follow up attempts are possible. Further information is requested.
Headache, body ache, fever, chills...Extreme Nausea that has lasted 7 days so far
Tingling left hand last two fingers, left arm, left side of face & left leg on & off.
Pt developed fever, chills, headache, myalgias within 5 hours of vacc. subsequent synovitis (knees), 10 x 7 cm local reaction right arm developed within 72 hours and persisted 7 days.  Treated with ceftin for oral infection.
This spontaneous report as received from a nurse refers to a unspecified numbers of patients. On an unspecified date, the patients were vaccinated with (unspecified number) PROQUAD (Merck) lot # K001853 (expiration date 06-AUG-2015), J006869 (expiration date 14-DEC-2014), J000134 (expiration date 04-JUL-2014); dosage, indication and route of administration were not provided. It was reported that since 05-MAR-2014 PROQUAD (Merck) was exposed to temperature above 5F. Some of the temperatures went above 8F to an unspecified temperature on unspecified dates during 43 days time-frame. Reporter stated the PROQUAD (Merck) was exposed to 16F for 44 days time-frame. Additionally, there was a 14 hour time-frame. Additionally, there was a 14 hour time-frame that the product was exposed to 16F. These potentially improperly stored vaccines were given to an unspecified number of patients on unspecified dates. No known adverse effects were reported. This is one of several reports from the same source.
Vaccine administered: Moderna Lot #025J20-2A @ 1139 am  Patient reaction: itchiness + change in swallowing + lightheadedness  Action taken: self administered 50 mg PO benadryl pre vaccination per PCP. Approximately 30 minutes post  Vaccination symptoms present and throat reported as "swalling is different" self administered an additional 50 mg or personal PO Benadryl / 1200 pm VS BP 139/85 HR 62 spo2 97% RR 13  Outcome: no adverse events noted, patient reports improving symptoms at this time 1241 pm
I got the Moderna shot on Sunday. Today I have green poop. Is that a side effect?; This spontaneous case was reported by a consumer and describes the occurrence of FAECES DISCOLOURED (I got the Moderna shot on Sunday. Today I have green poop. Is that a side effect?) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Aug-2021, the patient experienced FAECES DISCOLOURED (I got the Moderna shot on Sunday. Today I have green poop. Is that a side effect?). At the time of the report, FAECES DISCOLOURED (I got the Moderna shot on Sunday. Today I have green poop. Is that a side effect?) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported.
1 DAY AFTER INJECT, PT COMPLAINED OF SWELLING, REDNESS AND SORENESS OF R. UPPER ARM, SEEN AND SYMPTOMS CONFIRMED BY DOCTOR
The pharmacist was advised that the patient reported warmness to the touch, soreness, redness, and hard to touch at injection site. The patient also reported dizziness and a headache. It is unclear when the actual adverse events started as the pharmacist was unable to reach the patient again after being notified on March 6th.
Patient says she has had radiating pain from her elbow to her ear on the same side as the administration site. She says it is aching and progressively worsening and started with the injection and radiated outwards. Patient is trying OTC meds but says none have alleviated the pain.
onset 2-3d p/vax; 2x3 cm swollen, red area of upper arm @ vax site; lasting several days; no known fever;
Information has been received from an RN concerning a pt who at an unspecified date was vaccinated with the 1st dose of Hep-B and subsequently, the pt experienced anxiety, restlessness, tightness of throat and a slight rash. The pt sought unspecified medical attention. Follow-up received on 8/2/00, stated that the pt had a lot of stress in her life. The pt called and went to see her physician and "her thyroid was low" so she was started on Synthroid. Following that visit, the pt became more anxious and the doctor dx'd hypothyroidism and anxiety. The pt went to the ER and had many subjective complaints but they were not seen by the doctors. The ER dx was hypothyroidism and possible increased thyroid. The pt went home and then "decided it was the Hep-B shot she had received days before". The pt called her doctor and was told to take a week off at work. The pt missed 7 working days of work. The reporter stated that "there were no objective findings to support any of the pt's complaints and she dx'd herself as a reaction to the Hep-B vaccine. The reporter also stated that "no doctor would say it was not or it was". The reporter stated that she thought it was an anxiety attack and the 1st and 2nd physicians were correct in their dx, however, physicians are not saying it wasn't the Hep-B vaccine. No further information is available.
Morning after started having swelling and pain in left armpit lasting 5 days. Second morning after started excessive sneezing and runny nose throughout the day lasting 1 day.
9/10/07 Tdap vaccination. S+S started 9/11/07 2am, client describes as "panic" type feelings - warm, flushed, racing heart. 9/11/07 visit to Dr. Tx was Solumedrol 125mg IM and Benadryl 50mg, Rx for Prednisone. Prednisone 50mg for 3d, 30mg for 3d, 20mg for 2d, 10mg for 2d. Client said the doctor thought it was the pertussis component.
I had slight rash from the first one; I haven't got the second one; This is a spontaneous report from a contactable consumer. A 58-years-old female patient received BNT162B2 (Formulation: Solution for injection; Batch/Lot Number: EW0191), dose 1 via an unspecified route of administration, administered in Arm Left on 19Jun2021 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included antidepressant therapy from an unknown date and unknown if ongoing mild Antidepressant. Concomitant medications included escitalopram (ESCITALOPRAM) taken for antidepressant therapy, start and stop date were not reported. On an unspecified date of Jun2021 consumer stated, Yes, I am at the health department to get a second Pfizer Vaccine (Pfizer Covid Vaccine) and I had slight rash from the first one and so they gave me this number to see, if it's okay to vaccinate me with the second dose and I had the first dose on June nineteenth (19Jun). consumer stated, how long do I have, I don't know. I haven't got the second one that's why I am calling you. I am here at the health department and wanted to get the second shot, but they won't unless you say it's okay. Consumer stated, the nurse at the Health Department said to call this number. I am trying to get my second dose, but they won't give it to me unless you say it's okay. Consumer stated, Yes, I take an antidepressant. It's Escitalopram (Not clarified hence not captured in tab) I didn't know I would be question on my medical stuff here, so I don't have my medical file. It's a generic. I take a mild Antidepressant. It's spelled ETC. Consumer stated, I had a general X-ray last week. The first vaccine it was in, it was like a sealed syringe. The patient did not receive any other vaccination within 4 weeks prior to vaccination. The patient underwent lab tests and procedures which included x-ray: unknown on an unspecified date of 2021. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
Chills, headache, body aches, tiredness, weakness - lasted 2 days. Tinnitus - started a day after vaccine and it is still going on.  This also happened after the 2 previous Covid vaccines that I received; however, I only now connected it to the vaccines. Symptoms had improved some from previous vaccine, but it is much worse since getting the 3rd vaccine.
This spontaneous case was reported by a consumer and describes the occurrence of COUGH (bad cough this morning), HYPERHIDROSIS (sweat), FATIGUE (Felt tired,fatigue), MYALGIA (Woke up with aches) and CHILLS (chills) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LOSARTAN POTASSIUM (LOSARTAN POTASSSIUM) and OMEPRAZOLE (OMEPRAZOLE ABBOTT) for an unknown indication.    On 11-Jan-2021 at 8:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced FATIGUE (Felt tired,fatigue), MYALGIA (Woke up with aches), CHILLS (chills) and PYREXIA (fever). On 13-Jan-2021, the patient experienced COUGH (bad cough this morning). On an unknown date, the patient experienced HYPERHIDROSIS (sweat). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of UNK dosage form. At the time of the report, COUGH (bad cough this morning) outcome was unknown and HYPERHIDROSIS (sweat), FATIGUE (Felt tired,fatigue), MYALGIA (Woke up with aches), CHILLS (chills) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, Body temperature: 101.4 (High) high.         The patient reported taking an unspecified nasal spray concomitantly.  In the afternoon of 11JAN2021, the patient felt tired and took a nap. He woke up with aches, chills , fever and fatigue. (which lasted for about 48 hours).  The patient self-treated with ibuprofen, which helped the fever. On 13JAN2021, the patient developed a "bad cough" which was concerning. The patient experienced fatigue for 4 or 5 days.   This case was linked to MOD-2021-075444 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jan-2021: Reporter address and Lot # provided, additional events and event details reported On 12-Apr-2021: Completed ADR Form: includes patient demographic information and medical history, event outcomes updated; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pain on arm where the vaccine was administered (immediate and ongoing after 11 days) Nausea, headache, tightness in chest, metallic taste in mouth (30 mins after vaccine until 5 hours after) Extreme tiredness, blurry vision, heavy eyelids (30 mins after vaccine and ongoing after 11 days) Cold Sores (3-5 days after vaccine) Warts on fingers (7 days after vaccine) Vaginal Vesicles (5-7 days after vaccine) Oral vesicles and irritated gums (9 days after vaccine and ongoing)
Subsequent to receiving one dose of varicella virus vaccine live the pt experienced a mild breakthrough case of chickenpox. Ten days post onset the pt recovered.
16 year old patient received a Pfizer Booster vaccine prior to the age of 18 and prior to 6 months after completion of initial series. Patient's parent was notified of mistake. No treatment needed, patient has had Pfizer previously for the first two doses of series
Redness around injection area. I marked the redness, next day redness is moving outside of the border.
Noticed swelling and redness on upper left arm next day. Localized R and N.